UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 4, 2025
Accession Number:
0002007919-25-000075
Submission Type:
POS AM
CIK:
0002007919
Company Name:
Inhibrx Biosciences, Inc.
File Number:
333-280127